The insulin proreceptor is cleaved by limited proteolysis post-translationally at an Arg-Lys-Arg-Arg site to generate its mature alpha- and beta-subunit form. An 35S-labelled insulin proreceptor substrate preparation and a 15-mer peptide substrate that mimics the amino acid sequence around and including the insulin proreceptor processing site (IRP-peptide) has revealed an endopeptidase activity that catalyses insulin proreceptor cleavage in a rat liver subcellular fraction. Under optimal conditions, normal 35S-labelled insulin proreceptor substrate processing by this fraction was quantitative. This fraction was not able to process an 35S-labelled insulin proreceptor variant substrate (where the Arg-1 of the tetrabasic cleavage site had been replaced by Ala-1), similarly to previous in vivo observations, suggesting that this endopeptidase activity has physiological relevance. Biochemical characterization of the insulin proreceptor/IRP-peptide processing revealed this rat liver endopeptidase activity to have a broad pH range (> 70% maximal activity between pH 5.5 and 10.0) and a pH optimum of pH 8-10. It was Ca(2+)-dependent activity, maximally active between 0.5 and 5 mM Ca2+ and half-maximally activated between 50 and 90 microM Ca2+. Endoproteolytic activity was not inhibited by group-specific inhibitors of serine-, cysteinyl or aspartyl proteinases or by 1,10-phenanthroline; however, EDTA and 1,2-cyclohexanediaminetetraacetic acid did inhibit the activity, but this was accounted for by Ca2+ chelation. The IRP-peptide substrate assay enabled measurement of an apparent Km of 22 microM and a Vmax of 18.6 pmol/min for this endopeptidase activity. These biochemical characteristics suggest that insulin proreceptor processing endopeptidase activity to be a legitimate member of the Kex2-related proprotein convertase family. Immunoblotting detected furin and PACE4 proteins (both members of this family) to be present in the rat liver subcellular fraction containing insulin proreceptor processing activity. Since the biochemical characteristics of the insulin proreceptor processing endopeptidase activity mostly resembled those of furin activity, it is likely that insulin proreceptor proteolytic maturation can be catalysed by furin in the liver.
Skip Nav Destination
Article navigation
July 1994
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
July 01 1994
A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor
C Alarcón;
C Alarcón
*E.P. Joslin Research Laboratory, Joslin Diabetes Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for other works by this author on:
B Cheatham;
B Cheatham
*E.P. Joslin Research Laboratory, Joslin Diabetes Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for other works by this author on:
B Lincoln;
B Lincoln
*E.P. Joslin Research Laboratory, Joslin Diabetes Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for other works by this author on:
C R Kahn;
C R Kahn
*E.P. Joslin Research Laboratory, Joslin Diabetes Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for other works by this author on:
K Siddle;
K Siddle
†Deparment of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QR, U.K.
Search for other works by this author on:
C J Rhodes
C J Rhodes
*E.P. Joslin Research Laboratory, Joslin Diabetes Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, U.S.A.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1994 The Biochemical Society, London
1994
Biochem J (1994) 301 (1): 257–265.
Citation
C Alarcón, B Cheatham, B Lincoln, C R Kahn, K Siddle, C J Rhodes; A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor. Biochem J 1 July 1994; 301 (1): 257–265. doi: https://doi.org/10.1042/bj3010257
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.